Neuropathological changes in ten cases of neuronal intermediate filament inclusion disease (NIFID):: a study using α-internexin immunohistochemistry and principal components analysis (PCA)

被引:11
作者
Armstrong, R. A. [1 ]
Kerty, E.
Skullerud, K.
Cairns, N. J.
机构
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
[2] Univ Oslo, Dept Neurol, Oslo, Norway
[3] Univ Oslo, Dept Pathol, Rikshosp, Oslo, Norway
[4] Washington Univ, Sch Med, Dept Neurol, St Louis, MO USA
[5] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
基金
英国惠康基金;
关键词
neurofilament intermediate filament inclusion disease (NIFID); neuronal inclusions (NI); swollen achromatic neurons (SN); lesion density; principal components analysis (PCA);
D O I
10.1007/s00702-005-0387-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Ten cases of neuronal intermediate filament inclusion disease (NIFID) were studied quantitatively. The alpha-internexin positive neurofilament inclusions (NI) were most abundant in the motor cortex and CA sectors of the hippocampus. The densities of the NI and the swollen achromatic neurons (SN) were similar in laminae II/III and V/VI but glial cell density was greater in V/VI. The density of the NI was positively correlated with the SN and the glial cells. Principal components analysis (PCA) suggested that PC1 was associated with variation in neuronal loss in the frontal/temporal lobes and PC2 with neuronal loss in the frontal lobe and NI density in the parahippocampal gyrus. The data suggest: 1) frontal and temporal lobe degeneration in NIFID is associated with the widespread formation of NI and SN, 2) NI and SN affect cortical laminae II/III and V/VI, 3) the NI and SN affect closely related neuronal populations, and 4) variations in neuronal loss and in the density of NI were the most important sources of pathological heterogeneity.
引用
收藏
页码:1207 / 1215
页数:9
相关论文
共 22 条
[1]   Quantification of pathological lesions in the frontal and temporal lobe of ten patients diagnosed with Pick's disease [J].
Armstrong, RA ;
Cairns, NJ ;
Lantos, PL .
ACTA NEUROPATHOLOGICA, 1999, 97 (05) :456-462
[2]   Neuropathological heterogeneity in Alzheimer's disease: A study of 80 cases using principal components analysis [J].
Armstrong, RA ;
Nochlin, D ;
Bird, TD .
NEUROPATHOLOGY, 2000, 20 (01) :31-37
[3]   Correlations between the morphology of diffuse and primitive beta-amyloid (A beta) deposits and the frequency of associated cells in Down's syndrome [J].
Armstrong, RA .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1996, 22 (06) :527-530
[4]  
Armstrong RA, 2000, NEUROSCI RES COMMUN, V27, P85
[5]   A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration [J].
Armstrong, RA ;
Cairns, NJ ;
Lantos, PL .
EXPERIMENTAL NEUROLOGY, 2000, 163 (02) :348-356
[6]   Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS [J].
Bigio, EH ;
Lipton, AM ;
White, CL ;
Dickson, DW ;
Hirano, A .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2003, 29 (03) :239-253
[7]   Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia [J].
Boeve, BF ;
Lang, AE ;
Litvan, I .
ANNALS OF NEUROLOGY, 2003, 54 :S15-S19
[8]   Staging disease severity in pathologically confirmed cases of frontotemporal dementia [J].
Broe, M ;
Hodges, JR ;
Schofield, E ;
Shepherd, CE ;
Kril, JJ ;
Halliday, GM .
NEUROLOGY, 2003, 60 (06) :1005-1011
[9]  
Cairns NJ, 2004, NEUROLOGY, V63, P1376
[10]   α-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease [J].
Cairns, NJ ;
Zhukareva, V ;
Uryu, K ;
Zhang, B ;
Bigio, E ;
Mackenzie, IRA ;
Gearing, M ;
Duyckaerts, C ;
Yokoo, H ;
Nakazato, Y ;
Jaros, E ;
Perry, RH ;
Lee, VMY ;
Trojanowski, JQ .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (06) :2153-2161